BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

BioNews
Biotechnology, Pharmaceutical and Life Science News
search help

Search Results

Documents 1-25 out of over 1000 found
  Current Search:  parkinson: 1069     

HTML
100%
Communication breakdown: what happens to nerve cells in Parkinson's disease
A new study from The Montreal Neurological Institute and Hospital The Neuro - at McGill University is the first to discover a molecular link between Parkinson's disease and defects in the ability of nerve cells to communicate.

The study, published in...

EurekAlert!:  Feb 10 2010 12:44AM
Matching: parkinson
Find similar documents
HTML
100%
Parkinson's Linked to Industrial Cleaner
(Ivanhoe Newswire) -- Workers exposed to tricholorethylene (TCE), a chemical once widely used to clean metal such as auto parts, may be at significant risk of developing Parkinson's disease.

"This is the first time a population-based study has confirmed...

Medical Breakthroughs:  Feb 9 2010 7:17AM
Matching: parkinson
Find similar documents
HTML
100%
Industrial Cleaner Linked To Increased Risk Of Parkinson's Disease
Industrial Cleaner Linked To Increased Risk Of Medical Medical Medical Worldwide Search / Oncology hip Funny Useful Websites Compare and save on surgery Medical and Clinical Translation Details of over 40,000 UK Specialists and over 42,000 GPs medical software...
MediLexicon:  Feb 9 2010 3:58AM
Matching: parkinson
Find similar documents
HTML
100%
Targacept Awarded a Grant from The Michael J. Fox Foundation to Conduct Biomarker Research for Parkinson's Dis
- Targacept, Inc.

(NASDAQ: TRGT), a clinical-stage biopharmaceutical company developing novel NNR Therapeutics (TM), today announced that it has been awarded a grant of $304,000 from (MJFF).

The grant is to fund a project entitled: Development of an alpha6*...

Pharma Live:  Feb 9 2010 5:13AM
Matching: parkinson
Find similar documents
HTML
100%
Parkinson's Disease Risk Increases With Use of Industrial Cleaner
A study released today says that workers exposed to tricholorethylene (TCE), a chemical once widely used to clean metal such as auto parts, may be at a significantly higher risk of developing Parkinson's disease.

The study will be presented at the...

MedIndia:  Feb 9 2010 3:40AM
Matching: parkinson
Find similar documents
HTML
100%
Cleaning Agent Tied to Parkinson's in Study
MONDAY, Feb.

8 (HealthDay News) -- The industrial cleaner trichloroethylene (TCE) has been linked to an increased risk of Parkinson's disease, U.S.

researchers say.

'TCE was once a popular industrial solvent used in dry cleaning and to clean grease...

MedicineNet.com:  Feb 9 2010 4:16PM
Matching: parkinson
Find similar documents
HTML
100%
Targacept receives grant for developing alpha6*-selective NNR Imaging Agent as Parkinsons disease biomarker
Targacept, Inc.

(NASDAQ: TRGT), a clinical-stage biopharmaceutical company developing novel NNR Therapeutics (TM), today announced that it has been awarded a grant of $304,000 from The Michael J.

Fox Foundation for Parkinson's Research (MJFF).

The...

News-Medical.Net:  Feb 9 2010 10:49AM
Matching: parkinson
Find similar documents
HTML
100%
Targacept Awarded a Grant from The Michael J. Fox Foundation to Conduct Biomarker Research for Parkinsons Disease
WINSTON-SALEM, N.C.--(BUSINESS WIRE)--Targacept, Inc.

(NASDAQ: TRGT), a clinical-stage biopharmaceutical company developing novel NNR Therapeutics (TM), today announced that it has been awarded a grant of $304,000 from (MJFF).

The grant is to fund a project...

Yahoo! Canada:  Feb 9 2010 1:32AM
Matching: parkinson
Find similar documents
HTML
100%
Geisinger Hospitals Offer Unique Treatment For Movement Disorders
Deep Brain Stimulation (DBS), a new treatment being offered at Geisinger Medical Center (GMC) and Geisinger Wyoming Valley Medical Center (GWV), can dramatically reduce symptoms of movement disorders.

Parkinson's disease and other movement disorders can...

Medical News Today:  Feb 9 2010 5:03PM
Matching: parkinson
Find similar documents
HTML
100%
New revolutionary treatment for patients suffering from movement disorders
Deep Brain Stimulation (DBS), a new treatment being offered at Geisinger Medical Center (GMC) and Geisinger Wyoming Valley Medical Center (GWV), can dramatically reduce symptoms of movement disorders.

Parkinson's disease and other movement disorders can...

News-Medical.Net:  Feb 9 2010 6:36AM
Matching: parkinson
Find similar documents
HTML
100%
Neuraltus Pharmaceuticals Names Andrew Gengos President and CEO
PALO ALTO, CA, Feb 8 --(HSMN NewsFeed)-- Neuraltus Pharmaceuticals, a privately held biopharmaceutical company dedicated to developing and commercializing products that address critical unmet needs primarily in the treatment of neurodegenerative diseases,...
Healthcare Sales & Marketing Network:  Feb 9 2010 1:17PM
Matching: parkinson
Find similar documents
HTML
100%
Reportlinker Adds What's Next in Vaccines? HIV, Malaria, Rabies, MRSA, and 30 Other Vaccine Targets in the 201
NEW YORK, Feb.

9 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: The global market for human vaccines has experienced strong growth in the past few years, and R&D departments at many...

Montana's News Station:  Feb 9 2010 11:20PM
Matching: parkinson
Find similar documents
HTML
100%
AMT To Present at the BIO CEO & Investors Conference ' 9th February 2010
CNS Diseases Breaking News News source: Business Wire AMT is a leader in the field of gene therapy.

Its first product is in registration in EU for Lipoprotein Lipase Deficiency, an orphan condition.

AMT's other development programmes include: Hemophilia, ...

Genetic Engineering News:  Feb 9 2010 10:57PM
Matching: parkinson
Find similar documents
HTML
100%
XenoPort Announces Extension of the Horizant(TM) PDUFA Date to February 11, 2010
(BUSINESS WIRE) ----XenoPort, Inc.

(Nasdaq:XNPT) announced today that the U.S.

Food and Drug Administration (FDA) will not be taking an action today on the Horizant (gabapentin enacarbil) new drug application (NDA) for moderate-to-severe primary Restless...

FOXBusiness.com:  Feb 9 2010 10:41PM
Matching: parkinson
Find similar documents
HTML
100%
XenoPort Announces Extension of the Horizant(TM) PDUFA Date to February 11, 2010
(BUSINESS WIRE) ----XenoPort, Inc.

(Nasdaq:XNPT) announced today that the U.S.

Food and Drug Administration (FDA) will not be taking an action today on the Horizant (gabapentin enacarbil) new drug application (NDA) for moderate-to-severe primary Restless...

FOXBusiness.com:  Feb 9 2010 10:38PM
Matching: parkinson
Find similar documents
HTML
100%
Anticholinergic activity and cognitive decline in Parkinson's disease
_ Anticholinergic activity and cognitive decline in Parkinson's disease.
Journal of Neurology, Neurosurgery & Psychiatry:  Feb 9 2010 10:31PM
Matching: parkinson
Find similar documents
HTML
100%
Use of drugs with anticholinergic effect and impact on cognition in Parkinson's disease: a cohort study
_ Use of drugs with anticholinergic effect and impact on cognition in Parkinson's disease: a cohort study.
Journal of Neurology, Neurosurgery & Psychiatry:  Feb 9 2010 10:30PM
Matching: parkinson
Find similar documents
HTML
100%
Comparative analysis of gait and speech in Parkinson's disease: hypokinetic or dysrhythmic disorders?
_ Comparative analysis of gait and speech in Parkinson's disease: hypokinetic or dysrhythmic disorders?.
Journal of Neurology, Neurosurgery & Psychiatry:  Feb 9 2010 10:30PM
Matching: parkinson
Find similar documents
HTML
100%
Cancer in patients with motor neuron disease, multiple sclerosis and Parkinson's disease: record linkage studi
_ Cancer in patients with motor neuron disease, multiple sclerosis and Parkinson's disease: record linkage studi.
Journal of Neurology, Neurosurgery & Psychiatry:  Feb 9 2010 10:29PM
Matching: parkinson
Find similar documents
HTML
100%
XenoPort Announces Extension of the Horizant(TM) PDUFA Date to Fe...
Company: Xenoport Inc (XNPT) XenoPort, Inc.

(Nasdaq:XNPT) announced today that the U.S.

Food and Drug Administration (FDA) will not be taking an action today on the Horizant (gabapentin enacarbil) new drug application (NDA) for moderate-to-severe primary...

Zibb:  Feb 9 2010 10:07PM
Matching: parkinson
Find similar documents
HTML
100%
Drinking milk during pregnancy may lower baby's risk of MS
PAUL, Minn.

Drinking milk during pregnancy may help reduce your baby's chances of developing multiple sclerosis (MS) as an adult, according to a preliminary study released today that will be presented at the 's 62nd Annual Meeting in Toronto April 10 to April...

Genetic Engineering News:  Feb 9 2010 9:59PM
Matching: parkinson
Find similar documents
HTML
100%
XenoPort Announces Extension of the Horizant(TM) PDUFA Date to February 11, 2010
SANTA CLARA, Calif.--(BUSINESS WIRE)-- XenoPort, Inc.

(Nasdaq: XNPT) announced today that the U.S.

Food and Drug Administration (FDA) will not be taking an action today on the Horizant (gabapentin enacarbil) new drug application (NDA) for moderate-to-severe...

Street Insider:  Feb 9 2010 9:42PM
Matching: parkinson
Find similar documents
HTML
100%
XenoPort Announces Extension of the Horizant PDUFA Date to February 11, 2010
XenoPort, Inc.

(Nasdaq:XNPT) announced today that the U.S.

Food and Drug Administration (FDA) will not be taking an action today on the Horizant (gabapentin enacarbil) new drug application (NDA) for moderate-to-severe primary Restless Legs Syndrome (RLS),...

FinanzNachrichten.de:  Feb 9 2010 9:29PM
Matching: parkinson
Find similar documents
HTML
100%
XenoPort Announces Extension of the Horizant(TM) PDUFA Date to February 11, 2010
XenoPort, Inc.

(NASDAQ:XNPT) announced today that the U.S.

Food and Drug Administration (FDA) will not be taking an action today on the Horizant (gabapentin enacarbil) new drug application (NDA) for moderate-to-severe primary Restless Legs Syndrome (RLS),...

RBC Dain Rauscher:  Feb 9 2010 9:28PM
Matching: parkinson
Find similar documents
HTML
100%
XenoPort Announces Extension of the Horizant PDUFA Date to February 11, 2010
XenoPort Announces Extension of the Horizant PDUFA Date to February 11, 2010 SANTA CLARA, Calif.

- (BUSINESS WIRE) - XenoPort, Inc.

(Nasdaq:XNPT) announced today that the U.S.

Food and Drug Administration (FDA) will not be taking an action today on the...

NewsBlaze:  Feb 9 2010 9:27PM
Matching: parkinson
Find similar documents


 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.